Informed consent as documented by signature (see informed consent form)
Primary ITP according to the definition of Rodeghiero et al. (52) and a platelet count of <30x109/l
Age range: 18-45 years
Previously treated patients, with failure or intolerance to first-line therapy, or relapse after first-line therapy, i.e. corticosteroids, intravenous immunoglobulin (IVIG), or anti-D immunoglobulins
